business
Gilead Sciences (GILD) Acquires Tubulis for $3.15B to Expand Oncology Portfolio
Gilead Sciences (GILD) Acquires Tubulis for $3.15B to Expand Oncology Portfolio
Read full story on Yahoo Finance → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop